Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Capital Expenditures (2016 - 2025)

Ironwood Pharmaceuticals' Capital Expenditures history spans 16 years, with the latest figure at -$1000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to -$1000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $34000.0, a 76.06% decrease, with the full-year FY2025 number at $34000.0, down 76.06% from a year prior.
  • Capital Expenditures hit -$1000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $2000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for IRWD hit a ceiling of $211000.0 in Q4 2023 and a floor of -$27000.0 in Q4 2022.
  • Historically, Capital Expenditures has averaged $47533.3 across 5 years, with a median of $31000.0 in 2025.
  • Biggest five-year swings in Capital Expenditures: plummeted 121.09% in 2022 and later skyrocketed 881.48% in 2023.
  • Tracing IRWD's Capital Expenditures over 5 years: stood at $128000.0 in 2021, then plummeted by 121.09% to -$27000.0 in 2022, then skyrocketed by 881.48% to $211000.0 in 2023, then crashed by 92.42% to $16000.0 in 2024, then crashed by 106.25% to -$1000.0 in 2025.
  • Business Quant data shows Capital Expenditures for IRWD at -$1000.0 in Q4 2025, $2000.0 in Q3 2025, and $2000.0 in Q2 2025.